• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Eli Lilly

Biotech

FDA shuts down fast approval for Lilly's Alzheimer's med

Eli Lilly’s bid for an accelerated approval of Alzheimer’s disease drug donanemab has been shut down by the FDA.
Annalee Armstrong Jan 19, 2023 7:41pm

Concert joins Sun Pharma's symphony in $576M acquisition

Jan 19, 2023 11:30am

Lilly CMO: 'We need to leave J.P. Morgan and get back to work'

Jan 9, 2023 2:36pm

Lilly pays $55M to ride TRex into regulatory T-cell space

Jan 9, 2023 9:10am

Lilly pays $55M to join AbbVie on AAV specialist's partner list

Jan 4, 2023 7:45am

Lilly doubles down on ProQR's RNA tech in $75M deal expansion

Dec 22, 2022 10:38am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy